Impact of the COVID-19 pandemic on the complete rehabilitation journey of hip fracture patients in Italy: From surgical admission to rehabilitation facility discharge
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0305966 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Heba Safwat Mhmoued Abdo Elhadidy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health Sciences and Pediatrics, Università di Torino, Torino, Italy. Hauptthemen laut MEDLINE: COVID-19, Hip Fractures, Patient Discharge, Length of Stay. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The COVID-19 pandemic led to a significant reorganization of health services, potentially affecting the quality of care for major public health concerns such as proximal femoral fractures. This study aimed to investigate potential changes in the timing of various steps in the patient journey after a hip fracture during the pandemic in Piedmont, a region in Northern Italy.
Methods
A retrospective study was conducted on the discharge records of patients aged 65 or older who were admitted for hip surgery following a femur fracture in 2019 and 2020. The study examined four-time steps: duration from hospital admission to surgery, length of hospital stay, interval between hospital discharge and admission to the rehabilitation facility, and duration of stay at the rehabilitation facility. To mitigate biases linked to sex and age factors, groups well-balanced across 2019 and 2020 were created using propensity score estimation.
Results
The dataset consisted of two cohorts of 583 patients each for the years 2019 and 2020. The average duration from admission to surgery was approximately 1.9 days in both years, with 75% of patients undergoing surgery within 2 days of hospital admission. The average hospital stay reduced from 13.49 days in 2019 to 11.34 days in 2020. The gap between hospital discharge and admission to rehabilitation was approximately 10–12 days, and the average duration of stay at the rehabilitation facility was about 31.6 days.
Discussion
The study indicates that healthcare systems can exhibit resilience and adaptability, even during a global pandemic, to ensure high-quality and safe standards of care. However, further long-term studies are needed to fully understand the pandemic’s impact on primary health outcomes following hip replacement surgery and subsequent rehabilitation. The potential role of telemedicine in reducing the time between steps also warrants further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Public Health Sciences and Pediatrics, Università di Torino, Torino, Italy.
- Department of Control and Computer Engineering, Politecnico di Torino, Torino, Italy.
- Regional Public Health Observatory, Epidemiology Unit, Local Healthcare Authority ASL TO3, Grugliasco, Italy.
ORCID-Profile: Heba Safwat Mhmoued Abdo Elhadidy
Zitieren
APA
Elhadidy, H. S. M. A., Politano, G., Onorati, R., Catozzi, D., & Gianino, M. M. (2024). Impact of the COVID-19 pandemic on the complete rehabilitation journey of hip fracture patients in Italy: From surgical admission to rehabilitation facility discharge. PLOS ONE. https://doi.org/10.1371/journal.pone.0305966
Vancouver
Elhadidy HSMA, Politano G, Onorati R, Catozzi D, Gianino MM. Impact of the COVID-19 pandemic on the complete rehabilitation journey of hip fracture patients in Italy: From surgical admission to rehabilitation facility discharge. PLOS ONE. 2024. doi:10.1371/journal.pone.0305966
BibTeX
@article{Elhadidy2024,
author = {Elhadidy, Heba Safwat Mhmoued Abdo and Politano, Gianfranco and Onorati, Roberta and Catozzi, Dario and Gianino, Maria Michela},
title = {Impact of the COVID-19 pandemic on the complete rehabilitation journey of hip fracture patients in Italy: From surgical admission to rehabilitation facility discharge},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0305966}
}
EUVIMED